While the implication and interaction in glioma biology remains unelucidated, the dual inhibitory effect of ALLO and THDOC through GABA-AR on TLR-4 proinflammation pathways remains an exciting venture for future research into molecular targets of glioma and GBM hallmarks [45,59]. This evidence concerns the gene TLR4 and central nervous system cancer.